Pierre Fabre
Manufacturing · France · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
1 Avenue D'albi, Castres, Occitania, 811...Phone Number
+33 563714200Website
www.pierre-fabre.comRevenue
$300 MillionIndustry
About Pierre Fabre
Pierre Fabre Org Chart
Financial Controller
Financial Controller
Senior Financial Controller
Contraloria
Controleur
Country, Financial Controller (Japan)
Is Pierre Fabre your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pierre Fabre had a recent Job posting/layoffs
Check if Pierre Fabre has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Pierre Fabre launches new products
Congratulate Masked Content for being promoted to Masked Content at Pierre Fabre
Check out if Pierre Fabre is spiking on competitors!
Earning: See what the market has to say on Pierre Fabre recently announced quarterly report
Pierre Fabre, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Pierre Fabre has new funding data
Recommended Actions
Reach out to Masked Content who joined Pierre Fabre as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Pierre Fabre is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pierre Fabre is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pierre Fabre.
Pierre Fabre Tech Stack
A closer look at the technologies used by Pierre Fabre
Most Recent Scoops
Pierre Fabre News & Media
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
European approval is based on results from the Phase 3 BREAKWATER trial, which demonstrated that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and progression-free...Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and...Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the...Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pierre Fabre
Founded in 195 and headquartered in Paris, France, Pierre Fabre is a private pharmaceuticals and dermo-cosmetics company. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the Europe and Asia market-leader brand Eau Thermale Avène).... Read More
